New regulation mechanisms of osteoclast differentiation

Osteoclasts play a crucial role in both physiological and pathological bone resorption. It is, thus, of compelling importance to understand the molecular mechanisms of osteoclast regulation. Because receptor activator of nuclear factor‐κB ligand (RANKL) is the key cytokine that induces osteoclast di...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the New York Academy of Sciences Vol. 1240; no. 1; pp. E13 - E18
Main Authors Nakashima, Tomoki, Takayanagi, Hiroshi
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.12.2011
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Osteoclasts play a crucial role in both physiological and pathological bone resorption. It is, thus, of compelling importance to understand the molecular mechanisms of osteoclast regulation. Because receptor activator of nuclear factor‐κB ligand (RANKL) is the key cytokine that induces osteoclast differentiation, we have focused on the investigation of RANKL signaling and RANKL‐expressing cells. Here, we summarize the recent advances in the understanding of osteoclastogenic signaling and the cells that express RANKL in the context of osteoimmunology. The scope of osteoimmunology has been extended to now encompass a wide range of molecular and cellular interactions, and its framework provides a scientific basis for future therapeutic approaches to diseases related to the bone and/or immune systems.
Bibliography:ArticleID:NYAS6373
ark:/67375/WNG-GCV2W9RB-G
istex:D3DF1328A5B88C4E750A44270EF21236ED20EEBB
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0077-8923
1749-6632
DOI:10.1111/j.1749-6632.2011.06373.x